Bortezomib Booms For Stada As Russian Problem Remains

Turnaround Strategy Is In The Works In Russia

 
• By Dean Rudge
  
Rock_Climber_Greece
Stada's sales climbed by 12% in 2019 following the bortezomib launch • Source: Shutterstock

More from Earnings

More from Business